Sobre
Dr. Ali Chamseddine is a Consultant Medical Oncologist from France, holding dual board certifications in medical oncology and clinical haematology, as well as MD and PhD degrees. He gained expertise at the esteemed Gustave Roussy Cancer Center in Villejuif, France, where he served as a senior medical oncology consultant. Dr. Chamseddine further honed his skills through a post-doctoral fellowship at the Division of Cancer Medicine, Leukaemia Department, at the renowned MD Anderson Cancer Center in Houston, Texas, USA.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
Throughout his career, Dr. Chamseddine has been deeply involved in research, with over 50 publications in prestigious journals, including the New England Journal of Medicine. Dr. Chamseddine's clinical expertise spans various areas of oncology, with a primary focus on Precision Oncology, Gastrointestinal Tumours, Breast and Genitourinary Tumours, and Lung Cancer.
He is an active member of esteemed professional organisations such as the European Society of Medical Oncology (ESMO), the American Society of Clinical Oncology (ASCO), the American Society of Hematology (ASH), and the European Hematology Association (EHA), among others.
Dr. Chamseddine's specific areas of interest include gastrointestinal cancers, breast cancer, genitourinary cancers, lung cancer, gynecologic cancers, central nervous system cancers, and soft-tissue sarcomas. He is also deeply committed to palliative and supportive care in cancer patients. Dr. Chamseddine focuses on developing patient-centric and personalised treatment approaches, identifying predictive markers for better benefit-risk balance of anticancer drugs, and implementing liquid biopsy for improved molecular characterization of cancers.
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr. Ali Chamseddine
Educação e formação
-
2007–2013 MD · Medicine and Surgery
-
2013–2017 Residency · Oncologia
Carreira e nomeações
-
2017-09–2018-08 Junior consultant
Licenças e seguros
Licenças médicas
AE — Organización Médica Colegial de España (OMC)
Certificações do conselho
European Board of Oncologia
Seguro de responsabilidade profissional:
Allianz Professional · 5,000,000 EUR cobertura · No claims on file
Procedimentos realizados
| Procedimento | Código | Total acumulado |
|---|---|---|
| GP consultation | 99213 | 130 |
| Annual physical exam | 99395 | 2,884 |
| Vaccination administration | 90471 | 1,828 |
| Minor procedure (skin) | 17110 | 1,267 |
Serviços e preços
| Serviço | Duração | Modalidade | Preço |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 270.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 360.00 EUR |
Consultório, equipa e na prática
Vídeos
Investigação e publicações
índice h: 11 · i10: 3
-
Validation of clinical scoring in Oncologia
DOI: 10.7129/euroclin.2026.0 · PMID: 37579667 · citado por 130
-
Long-term follow-up of Oncologia across AE
DOI: 10.5594/euroclin.2025.1 · PMID: 31987343 · citado por 200
-
Validation of clinical scoring in Oncologia
DOI: 10.6633/euroclin.2024.2 · PMID: 37865520 · citado por 118
Palestras convidadas
- Practical updates in Oncologia European Annual Congress (Oncologia) · Vienna · 2024 · invited
- Single-centre experience in Oncologia National Society Meeting · Dubai · 2023 · oral abstract
Prémios e afiliações
Prémios
- 🏆 Top-rated Oncologia — Dubai · EuroClinics Patient Choice · 2025 · regional
Filiações em sociedades
- WONCA Europe — Family Doctors — Member · Desde 2018
- national college of family doctors — Member · Desde 2018
- European Union of Medical Specialists (UEMS) — Member · Desde 2018
Artigos deste médico
- Patient education Patient guide to Oncologia
- Awareness When should you see a oncologia?
Para pacientes internacionais
- Coordenador
- Patient liaison · ali.chamseddine@euroclinics.example
Localização
1 etiquetaAvaliações dos pacientes
Partilhe a sua experiência — ajude outros pacientes a encontrar o médico certo. Escrever uma avaliação →
Avaliações recentes
-
★★★★★ ✓ Verificado Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
-
★★★★★ ✓ Verificado Took time to listen and reviewed all my previous results. I would absolutely recommend.
-
★★★★☆ ✓ Verificado Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
Especialistas semelhantes
Ver todos →
Dr Charlotte Rees
Oncologia · Winchester
Professor Hany Mohamad Eldeeb
Oncologia · Milton Keynes
Professor Jonathan Ledermann
Oncologia · London
Dr Stephen Morris
Oncologia · London
Dr Fharat Raja
Oncologia · London
Dr Angela Yates
Oncologia · Brisbane
Dr Andrew Parasyn
Oncologia · Wahroonga
Dr Mark Nathan
Oncologia · London